Cannabis Concentrates Consumption Cultivation Science Strains

Far more potent than THC/CBD: Dr. Raphael Mechoulam, ‘father of cannabis research,’ explains his latest discovery

Professor Raphael Mechoulam, also known as the “father of cannabis research,” revealed his latest discovery, cannabidiolic acid methyl ester (EPM301), in 2020. The introduction of this new, patented compound (synthetic, fully stable acid-based cannabinoid molecules) caused a wave of excitement around the future of medicinal cannabis.

The compound in question was presented to the world in partnership with EPM, a global biotechnology company based in the U.S. that aims to bridge the gap between the cannabis and pharmaceutical industries.

During an exclusive conversation, CEO Reshef Swisa and Dr. Mechoulam, shared the history of the journey behind this revolutionary process and its significance in evolving the use of CBD as a pharmaceutical drug.

Meet EPM301

“EPM developed a method to work with the original substances of cannabis,” the Professor explained. “So, while everybody is discussing THC and CBD, these cannabinoids are actually a secondary substance; they only appear later in the plant.

To Read The Rest Of This Article By Javier Hasse on Benzinga

Published: October 01, 2021

SHARE
RELATED POSTS
Experiential Marketing Leads The Way For Cannabis Companies
Cannabis Brands Fork Over Cash For Retail Shelf Space
Pabst Blue Ribbon Cannabis-Infused Seltzer Launches in California

Leave Your Reply

*